Much evidence shows that high levels of NfL are present both in CSF and in the serum of ALS and FTD patients when compared with controls [103] and that they could be interpreted as a diagnostic and prognostic biomarker [104,105]. Here, NEFL is linked to amyotrophic lateral sclerosis.